This page contains the latest updates and news from BianchiSchwald, from press releases to publications by our lawyers, to changes in the legal landscape. Want to know more? Please contact us directly.
The listed company Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company entered into a senior secured loan agreement with funds managed by the US company Athyrium Capital Management, LP ("Athyrium").
Athyrium is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. Athyrium advises funds with over $ 4.6 billion in committed capital (www.athyrium.com).
BianchiSchwald acted as Swiss legal counsel to Athyrium together with Moore&Van Allen that acted as US counsel with respect to all legal aspects of the transaction including contractual, corporate and tax related matters.
The CHF 75 million senior secured loan will be used by Basilea for the repayment of its convertible bonds (ISIN CH0305398148), which are due in December 2022 in an outstanding nominal amount of approximately CHF 117 million. The senior secured loan has a two-year term and repayment is expected to start as of Q1 2023 on a quarterly basis. Interest payments, excluding fees, are expected to amount to an average of approximately CHF 1.25 million per quarter over the term.
The closing of the transaction has been announced on 21 September 2022 (www.basilea.com/news).
BianchiSchwald team was led by Hélène Weidmann (partner in the Corporate – M&A and capital market practice) and Thomas Goossens (partner, head of the banking & finance practice) and included Alexandra Schuvalov (associate, banking & finance), Joseph Merhai (partner, head of the tax practice), as well as Gianni Fera (managing associate, tax practice), Laurent Schenker (associate, tax practice), Christoph Gasser (partner, head of the IP and data protection practice) and Thierry Burnens (associate, IP and data protection).
We are proud to bring our contribution to the success of this transaction.
Unsere Abendveranstaltung "Aktuelles zum Arbeits- und Datenschutzrecht" konnte wieder erfolgreich durchgeführt werden, worüber wir uns freuen. Den zahlreichen Gästen, welche dies erst möglich gemacht haben, danken wir für deren aktive Teilnahme und den bereichernden Austausch im Rahmen des anschliessenden Apéro riche.
BianchiSchwald is pleased to announce that Dr. Despina Mavromati, LL.M, M.B.A., has joined the firm as of Counsel where she will focus on sports law, sports arbitration, international arbitration and EU law. Dr. Mavromati will significantly strengthen the sports practice team in Lausanne, offering top-notch services in international sports law matters.
Within the AGEFI’s supplement "Indices”, Alexandra Schuvalov and Manon Baur examine how the draft Ordinance on the Report on Climate Issues presented for consultation by the Federal Council in spring 2022 fails to convince the consulted entities on critical points, among which the lack of coherence with the ongoing reform at the European level and the absence of third-party auditing.
Wir freuen uns auf die Abendveranstaltung "Aktuelles zum Arbeits- und Datenschutzrecht" am Montag, 19. September 2022 in Zürich.
Moderator: Christoph Gasser
Für weitere Details und die Anmeldung nutzen Sie bitte den untenstehenden Link: https://bit.ly/3zHwmGL
Every year, law students receive the opportunity to look behind the scenes at BianchiSchwald's Zurich office during their semester break. This year again, we are providing a varied and practical training program in our practice areas over a period of four weeks. In addition, our student trainees get to know our locations in Switzerland on several excursions. Last week, one of the "highlights" was the construction site visit to the Swiss Life Arena in Zurich, the new "home base" of the ZSC Lions.